| 0.38 -0.022 (-5.4%) | 01-26 12:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.51 | 1-year : | 0.57 |
| Resists | First : | 0.44 | Second : | 0.49 |
| Pivot price | 0.41 |
|||
| Supports | First : | 0.36 | Second : | 0.3 |
| MAs | MA(5) : | 0.4 |
MA(20) : | 0.41 |
| MA(100) : | 0.62 |
MA(250) : | 0.99 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 20.7 |
D(3) : | 34.8 |
| RSI | RSI(14): 36.5 |
|||
| 52-week | High : | 2.51 | Low : | 0.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ VSEE ] has closed below the lower bollinger band by 2.0%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ VSEE ] is to continue within current trading range. It is unclear right now based on current values. 79.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.41 - 0.41 | 0.41 - 0.41 |
| Low: | 0.38 - 0.38 | 0.38 - 0.38 |
| Close: | 0.4 - 0.4 | 0.4 - 0.41 |
VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Wed, 14 Jan 2026
VSee Health Launches AI-Powered Rural Health Transformation Platform to Expand Specialty Care - Precedence Research
Tue, 13 Jan 2026
VSee Launches AI-driven Rural Health Transformation Platform - Nasdaq
Mon, 12 Jan 2026
VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital - Chartmill
Fri, 12 Dec 2025
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025 - ACCESS Newswire
Thu, 11 Dec 2025
VSee Health establishes Series B preferred stock with conversion and liquidation terms - Investing.com
Thu, 04 Dec 2025
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 33 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 16.1 (%) |
| Held by Institutions | 3.3 (%) |
| Shares Short | 673 (K) |
| Shares Short P.Month | 253 (K) |
| EPS | 0.46 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.34 |
| Profit Margin | -69.9 % |
| Operating Margin | -51.7 % |
| Return on Assets (ttm) | -26 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 18.7 % |
| Gross Profit (p.s.) | 0.23 |
| Sales Per Share | 0.43 |
| EBITDA (p.s.) | -0.2 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | 0.82 |
| PEG Ratio | 0 |
| Price to Book value | -1.16 |
| Price to Sales | 0.87 |
| Price to Cash Flow | -2.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|